Literature DB >> 22761175

Intravenous lipid emulsion therapy for sustained release diltiazem poisoning: a case report.

Ben J Wilson1, Jack S Cruikshank, Kim L Wiebe, Valerian C Dias, Mark C Yarema.   

Abstract

We present a case of refractory cardiogenic shock secondary to sustained release diltiazem poisoning.  Intravenous lipid emulsion therapy was initiated approximately 13 hours after ingestion. Vasopressors were weaned off hours after initiation of intravenous lipid emulsion therapy and the patient went on to make a full recovery.  This report adds to the paucity of data on intravenous lipid emulsion rescue therapy in sustained release diltiazem poisoning. We hypothesize that the intravenous lipid emulsion may have mediated its favorable hemodynamic effects via increases in myocardial calcium concentration with resultant increased inotropy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761175

Source DB:  PubMed          Journal:  J Popul Ther Clin Pharmacol        ISSN: 2561-8741


  3 in total

1.  Multi-modal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsion.

Authors:  Michael R Fettiplace; Kinga Lis; Richard Ripper; Katarzyna Kowal; Adrian Pichurko; Dominic Vitello; Israel Rubinstein; David Schwartz; Belinda S Akpa; Guy Weinberg
Journal:  J Control Release       Date:  2014-12-04       Impact factor: 9.776

2.  Severe diltiazem poisoning treated with hyperinsulinaemia-euglycaemia and lipid emulsion.

Authors:  Nadine Monteiro; Joana Silvestre; João Gonçalves-Pereira; Camila Tapadinhas; Vitor Mendes; Pedro Póvoa
Journal:  Case Rep Crit Care       Date:  2013-05-20

Review 3.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.